Actuate Therapeutics Stock Forecast - Price Action Indicator
| ACTU Stock | 5.45 0.41 7.00% |
Actuate Stock Forecast is based on your current time horizon.
At this time, the RSI of Actuate Therapeutics' share price is approaching 39. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Actuate Therapeutics, making its price go up or down. Momentum 39
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.30) | EPS Estimate Current Year (1.15) | EPS Estimate Next Year (1.28) | Wall Street Target Price 26.75 | EPS Estimate Current Quarter (0.32) |
Using Actuate Therapeutics hype-based prediction, you can estimate the value of Actuate Therapeutics Common from the perspective of Actuate Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Actuate Therapeutics after-hype prediction price | USD 5.45 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Actuate Therapeutics to cross-verify your projections. Actuate Therapeutics Additional Predictive Modules
Most predictive techniques to examine Actuate price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Actuate using various technical indicators. When you analyze Actuate charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| 0.39 | (0.42) |
| Check Actuate Therapeutics Volatility | Backtest Actuate Therapeutics | Information Ratio |
Actuate Therapeutics Trading Date Momentum
| On January 22 2026 Actuate Therapeutics Common was traded for 5.45 at the closing time. The top price for the day was 5.89 and the lowest listed price was 5.45 . The trading volume for the day was 86.9 K. The trading history from January 22, 2026 did not affect price variability. The overall trading delta against the current closing price is 7.16% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Actuate Therapeutics to competition |
Other Forecasting Options for Actuate Therapeutics
For every potential investor in Actuate, whether a beginner or expert, Actuate Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Actuate Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Actuate. Basic forecasting techniques help filter out the noise by identifying Actuate Therapeutics' price trends.Actuate Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Actuate Therapeutics stock to make a market-neutral strategy. Peer analysis of Actuate Therapeutics could also be used in its relative valuation, which is a method of valuing Actuate Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Actuate Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Actuate Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Actuate Therapeutics shares will generate the highest return on investment. By undertsting and applying Actuate Therapeutics stock market strength indicators, traders can identify Actuate Therapeutics Common entry and exit signals to maximize returns.
Actuate Therapeutics Risk Indicators
The analysis of Actuate Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Actuate Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting actuate stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.99 | |||
| Standard Deviation | 3.96 | |||
| Variance | 15.68 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Actuate Therapeutics
The number of cover stories for Actuate Therapeutics depends on current market conditions and Actuate Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Actuate Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Actuate Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Actuate Therapeutics Short Properties
Actuate Therapeutics' future price predictability will typically decrease when Actuate Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Actuate Therapeutics Common often depends not only on the future outlook of the potential Actuate Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Actuate Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 19.5 M | |
| Cash And Short Term Investments | 8.6 M | |
| Shares Float | 8.4 M |
Additional Tools for Actuate Stock Analysis
When running Actuate Therapeutics' price analysis, check to measure Actuate Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actuate Therapeutics is operating at the current time. Most of Actuate Therapeutics' value examination focuses on studying past and present price action to predict the probability of Actuate Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actuate Therapeutics' price. Additionally, you may evaluate how the addition of Actuate Therapeutics to your portfolios can decrease your overall portfolio volatility.